Ng HH, Jelinic M, Parry LJ, Leo C. Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice. Am J Physiol Heart Circ Physiol 309: H285-H296, 2015. First published May 8, 2015 doi:10.1152/ajpheart.00786.2014.-The vascular effects of exogenous relaxin (Rln) treatment are well established and include decreased myogenic reactivity and enhanced relaxation responses to vasodilators in small resistance arteries. These vascular responses are reduced in older animals, suggesting that Rln is less effective in mediating arterial function with aging. The present study investigated the role of endogenous Rln in the aorta and the possibility that vascular dysfunction occurs more rapidly with aging in Rln-deficient (Rln Ϫ/Ϫ ) mice. We compared vascular function and underlying vasodilatory pathways in the aorta of male wild-type (Rln ϩ/ϩ ) and Rln
mice at 4 and 16 mo of age using wire myography. Superoxide production, but not nitrotyrosine or NADPH oxidase expression, was significantly increased in the aorta of young Rln Ϫ/Ϫ mice, whereas endothelial nitric oxide (NO) synthase and basal NO availability were both significantly decreased compared with Rln ϩ/ϩ mice. In the presence of the cyclooxygenase inhibitor indomethacin, sensitivity to ACh was significantly decreased in young Rln Ϫ/Ϫ mice, demonstrating altered NO-mediated relaxation that was normalized in the presence of a membrane-permeable SOD or ROS scavenger. These vascular phenotypes were not exacerbated in old Rln Ϫ/Ϫ mice and, in most cases, did not differ significantly from old Rln ϩ/ϩ mice. Despite the vascular phenotypes in Rln Ϫ/Ϫ mice, endothelium-dependent and -independent vasodilation were not adversely affected. Our data show a role for endogenous Rln in reducing superoxide production and maintaining NO availability in the aorta but also demonstrate that Rln deficiency does not compromise vascular function in this artery or exacerbate endothelial dysfunction associated with aging. aorta; endothelium; nitric oxide; relaxin; superoxide
NEW & NOTEWORTHY

Unlike resistance arteries, endogenous relaxin has very little role to play in mediating vascular function in the aorta. However, relaxin deficiency in this artery is associated with increased basal superoxide production and decreased nitric oxide availability. These effects are not exacerbated by vascular aging.
THE VASCULAR EFFECTS of the peptide hormone relaxin (Rln) have been well established in humans and rodents and include decreased myogenic reactivity and enhanced flow-mediated vasodilation. In small resistance arteries, this occurs through endothelium-dependent activation of endothelin (ET) B receptors, matrix metalloproteinases, and increased nitric oxide (NO) production (10, 16, 18) . Chronic subcutaneous infusion and acute intravenous injection of Rln also selectively enhance bradykinin-mediated relaxation in rat mesenteric arteries (9, 14) . Similarly, aortic rings treated in vitro with TNF-␣ and coincubated with Rln also show improved ACh-mediated relaxation (5) . Furthermore, acute in vivo Rln treatment (6.5 h) improves endothelial function in the aorta of chow-fed but not high-fat diet-fed mice (1) . These vasorelaxant effects of Rln on arteries are not only mediated by NO via increased endothelial NO synthase (eNOS) phosphorylation and activity (5, 14) and increased inducible NOS (iNOS) expression (14) but also involve intermediate-conductance Ca 2ϩ -activated K ϩ channeldependent endothelium-derived hyperpolarization and prostacyclin (PGI 2 ) in the mesenteric arteries (14) . Thus, Rln may function through different vasodilatory pathways in conduit (i.e., aorta) versus resistance arteries (i.e., mesenteric artery). Flow-mediated vasodilation and myogenic responses to Rln are reduced in mesenteric arteries of older animals (22), suggesting that exogenous Rln is less effective as a mediator of arterial function with aging.
In addition to its vasodilatory effects, Rln attenuates the maximum contractile response to ET-1 in vitro (4) and 3 h after acute intravenous injection in vivo (14) . In the rat aorta, these effects are specifically mediated through ET B -dependent vasodilation, whereas in the mesenteric artery, endothelium-derived NO is involved. Rln treatment also attenuates the stimulated production of ROS, nitrotyrosine, and arginase II in rat aortic rings incubated with TNF-␣ (5). Endothelial dysfunction is a hallmark of aging and vascular disease and is characterized by impaired vascular reactivity resulting from reduced NO availability, increased circulating vasoconstrictors, and elevated vascular oxidative stress (8, 21) . Given that Rln and its receptor are both expressed in a number of blood vessels, including the aorta and renal, uterine, and mesenteric arteries (9, 17, 24) , and Rln appears to have several vasoprotective functions, we hypothesized that a lack of endogenous Rln may exacerbate or lead to the early onset of endothelial dysfunction associated with aging.
Very little work to date has investigated the role of endogenous Rln in the vasculature or the possibility that vascular aging occurs more rapidly in Rln-deficient (Rln Ϫ/Ϫ ) mice. Myogenic reactivity is increased and passive compliance is reduced in small renal arteries of male and female Rln Ϫ/Ϫ mice aged 5-7 mo (17). We recently reported vascular dysfunction in mesenteric arteries of Rln Ϫ/Ϫ mice aged 5 and 12 mo, with endothelium-dependent increases in phenylephrine-and thromboxane A 2 mimetic (U-46619)-evoked contraction and a reduction in endothelium-dependent relaxation (13) . The enhanced responsiveness to vasoconstrictors in Rln Ϫ/Ϫ mice is associated with impaired NO and prostanoid pathways, whereas impaired ACh-mediated relaxation is attributed to increased production of vasoconstrictor prostanoids (13) . However, these vascular phenotypes in the mesenteric artery do not appear to worsen with aging. Rln acts on its major receptor, Rln/insulin-like family peptide receptor 1 (RXFP1), which is differentially expressed in endothelial and vascular smooth muscle cells in different arteries, including the aorta (9) . Based on evidence that Rln treatment is capable of stimulating vasodilation in the aorta (1, 5) and endogenous Rln is produced by the aorta (17) and the fact that there are known functional differences between resistance and conduit arteries, we investigated vascular phenotypes attributed to Rln action on RXFP1 in the aorta and to what extent phenotypes in this artery are exacerbated by aging. We compared ACh and glyceryl trinitrate (GTN)-mediated relaxation and analyzed underlying vasodilatory pathways in the abdominal aorta of male Rln Ϫ/Ϫ and wild-type (Rln ϩ/ϩ ) mice at 4 and 16 mo of age.
MATERIALS AND METHODS
Animals. The present study used the original Rln Ϫ/Ϫ mouse backcrossed on a C57/BLK6J background to the F14 generation and Rln ϩ/ϩ littermates of the same strain. Male Rln ϩ/ϩ and Rln Ϫ/Ϫ mice were divided into the following two age groups: 1) 4 mo (mean age: 3.96 Ϯ 0.13 mo, n ϭ 45) and 2) 16 mo (mean age: 15.21 Ϯ 0.70 mo, n ϭ 22). Genotypes were confirmed by PCR analysis of genomic DNA from ear clips as previously described (7) . All mice were housed on a 12:12-h day/night cycle at a room temperature of 20 Ϯ 2°C in the School of BioSciences Animal Facility (The University of Melbourne) and were given ad libitum access to standard rodent chow (Barastock, VIC, Australia) and water.
Isolation of aortae. Mice were euthanized by isofluorane overdose followed by cervical dislocation. The whole aorta was isolated and immediately placed in ice-cold Krebs bicarbonate solution (120 mM NaCl, 5 mM KCl, 1.2 mM MgSO 4, 1.2 mM KH2PO4, 25 mM NaHCO3, 11.1 mM D-glucose, and 2.5 mM CaCl2) and then cleared of fat and connective tissues. The abdominal aorta was cut into 2-mm-long rings and used for functional experiments. The remaining aorta was snap frozen in liquid nitrogen for molecular experiments.
Wire myography. Aortic rings were mounted on a multiwire myograph system (620M, Danish Myo Technology, Aarhus, Denmark) and allowed to stabilize at zero tension for 15 min followed by a 30-min equilibration period at 5 mN. All experiments were performed at 37°C, and aortic rings were continuously bubbled with carbogen (95% O 2 and 5% CO2). Changes in isotonic tension were recorded using a Powerlab/LabChart data-acquisition system (AD Instruments, Bella Vista, NSW, Australia). Thirty minutes after equilibration at 5 mN, aortic rings were maximally contracted with the thromboxane A 2 mimetic U-46619 (1 M). Once the U-46619-induced maximum contraction reached a plateau (Fmax), aortic rings were washed with Krebs solution to regain their basal tension. They were then precontracted to ϳ50% Fmax using titrated concentrations of U-46619 (0.1-100 nM). ACh (10 M) verified endothelium integrity, and in all cases, ACh-induced relaxation was Ͼ80% of the precontracted tone. After several washouts, aortic rings were incubated with either with the NOS inhibitor N -nitro-L-arginine methyl ester hydrochloride (L-NAME; 200 M), the cyclooxygenase (COX) inhibitor indomethacin (1 M), the membrane-permeable SOD mimetic 4-hydroxy-TEMPO (tempol; 10 M) or the ROS scavenger apocynin (300 M) for 20 min. Dose-response curves to the endothelium-dependent relaxant ACh (0.1 nM-10 M) and endothelium-independent relaxant GTN (0.1 nM-10 M) were produced. At the completion of each dose-response curve, the K ϩ channel opener levcromakalim (LKM; 10 M) was added to achieve maximal relaxation (Rmax), which was comparable between all groups. Additionally, dose-response curves to U-46619 (0.1 nM-1 M) and the prostacyclin receptor agonist iloprost (1 nM-10 M) were produced. In a separate set of experiments, aortic rings were precontracted to ϳ25% Fmax using titrated concen- trations of U-46619 followed by the addition of L-NAME (200 M) to determine basal NO availability. Concentration-response curves were fitted to a sigmoidal curve using nonlinear regression (Prism, version 5.0, GraphPad Software, San Diego, CA) to calculate the sensitivity of each agonist (pEC 50). Rmax was measured as a percentage of LKM.
Superoxide measurement. Basal vascular superoxide production in segments of mouse aortae from 4-mo-old Rln ϩ/ϩ and Rln Ϫ/Ϫ mice was assessed by L012-enhanced chemiluminescence (12) . Thoracic aortae were cut into 2-to 3-mm segments and placed in separate wells of a 96-well optiplate containing 300 l Krebs-HEPES buffer (pH 7.4). They were allowed to equilibrate for 45 min at 37°C before the addition of L012 (100 M; Wako Pure Chemical Industries, ChuoKu, Osaka, Japan). L012-enhanced chemiluminescence was then measured using a POLARstar Optima photon counter (BMG Labtech, Melbourne, VIC, Australia). Superoxide production was calculated by subtracting the chemiluminescence signal obtained in blank wells from the signal detected in the well containing the aortic ring and then normalized to dry tissue weight (in mg).
Quantitative real-time PCR. Total RNA was extracted using TRI Reagent solution (Ambion, Mulgrave, VIC, Australia), as previously described (14, 24) , resulting in 260-to-280-nm absorbance values of Ͼ1.90. First-strand cDNA synthesis used the SuperScript III cDNA synthesis kit (Invitrogen, Mount Waverly, VIC, Australia) and 0.75 g RNA in a final reaction volume of 20 l. A randomly chosen control sample was used as the negative control without the addition of SuperScript enzyme mix to demonstrate the absence of PCR products from cDNA amplifications in the real-time PCR cycling. All RNA samples and negative controls were reverse transcribed in a single run using a MyCycler Thermal Cycler (Bio-Rad, Gladesville, NSW, Australia). Expression of Rxfp1, eNOS (Nos3), COX-1 (Ptgs1), COX-2 (Ptgs2), prostacyclin synthase (PTGIS), and PGI 2 receptor (Ptgir) was assessed by quantitative PCR using the Ϫ2
⌬CT method (where CT is threshold cycle) with ribosomal 18S (Rn18s) as the endogenous reference gene. Mouse-specific forward/reverse primers and 6-carbonyl fluorescein-labeled (FAM) Taqman probes (Biosearch Technologies, Novato, CA) were designed to span introns (Table 1) . Experiments were performed on the Applied Biosystems ViiA7 PCR machine (Life Technologies, Mulgrave, VIC, Australia) using Thermo-Fast 96-well reaction plates (Life Technologies) with triplicate samples of 10 l containing 2ϫ SensiMix (Bioline, Alexandria, NSW, Australia) and 10 M of primers and probe. For each sample, the mean Rn18s CT triplicate value was subtracted from the mean gene of interest triplicate CT value to normalize gene of interest expression to the reference gene. These normalized data (⌬CT) were then analyzed using the 2 Ϫ⌬CT method and presented as means Ϯ SE. Western blot analysis. Snap-frozen aortae (ϳ30 mg) were homogenized in 100 l ice-cold lysis buffer as previously described (11) . Total protein concentration of each sample was quantified using a BCA protein assay kit (ThermoScientific). Cu/Zn SOD (25 g) or 40 g protein homogenate (all other proteins) were subjected to SDS-PAGE and Western blot analysis using the appropriate primary mouse/rabbit antibodies for eNOS (catalog no. 9572S, Cell Signalling, Danvers, MA), phospho-Ser 1177 eNOS (catalog no. 612392), iNOS (catalog no. 610431), glycoprotein (gp)91 phox (catalog no. 611415, BD Transduction Laboratories, Lexington, KY), and Cu/Zn SOD (catalog no. SOD101, Stressgen Bioreagents, Victoria, BC, Canada) at a dilution of 1:1,000 or 1:2,000 (Cu/Zn SOD) overnight at 4°C. To normalize for the amount of protein, membranes were reprobed with a loading control antibody (actin, 1:2,000, Sigma, Castle Hill, NSW, Australia). Protein expression was detected using enhanced chemiluminescence (SuperSignal West Femto Chemiluminescent Substrate, ThermoScientific) after incubation with either anti-rabbit or antimouse horseradish peroxidase-conjugated secondary antibody (Millipore, Kilsyth, VIC, Australia) in 5% skim milk for 1 h at room temperature (1:2,000). Protein bands were quantified using densitometry and normalized to actin as the loading control.
Nitrotyrosine levels. Snap-frozen aortae were homogenized as described above in Western blot analysis. Total protein concentration of each sample was quantified using a BCA protein assay kit (ThermoScientific). Nitrotyrosine levels were then measured by competitive ELISA (catalog no. 17-376) according to the manufacturer's instructions (Upstate, Merck Millipore, Bayswater, VIC, Australia).
Localization of RXFP1 in the mouse aorta. RXFP1 was localized in the abdominal aorta using immunohistochemistry, as previously described (20) . Briefly, vessels were embedded in paraffin wax, cut into sections (5 m), and mounted on SuperFrost PLUS slides (MenzelGläser, Braunschweig, Germany). Sections of the abdominal aorta were incubated in Rodent M Block (Biocare Medical, Pike Lane, Concord, CA) for 30 min to block nonspecific binding and then with 0.72 g/ml monoclonal anti-human RXFP1 antiserum (H00059350-M01, Abnova, Walnut, CA) or mouse IgG (diluted to 0.72 g/ml, Dako, Braeside, VIC, Australia) as the negative control overnight at 4°C. The peptide fragment of human RXFP1 used to generate this antiserum shared 74% homology with mouse RXFP1, and the antiserum has been previously characterized in mouse reproductive tissues (17) . Immunoreactivity was detected using Mouse-On-Mouse HRPPolymer (BioCare Medical) and 3,3=-diaminobenzidine (DAB) as the chromagen substrate (BioCare Medical). To enhance the signal, sections were incubated in DAB Sparkle (BioCare Medical) for 15 s.
Drugs, chemicals, reagents, and other materials. All drugs were purchased from Sigma-Aldrich except for U-46619 and iloprost (Cayman Chemical, Ann Arbor, MI), GTN (Hospira, Lake Forest, IL) and LKM (Tocris Bioscience, Bristol, UK). They were dissolved in deionized water with the exception of U-46619 and iloprost, which were dissolved in 100% ethanol, GTN, which was dissolved in 50% ethanol and further diluted in deionized water, and LKM and apocynin, which were dissolved in DMSO. considered statistically significant. All results are presented as means Ϯ SE; n represents the number of animals per group.
RESULTS
Localization and expression of RXFP1 in the mouse aorta. It was first important to demonstrate RXFP1 in the mouse abdominal aorta. Immunoreactive RXFP1 was predominantly localized in vascular smooth muscle cells and, to a lesser extent, in endothelial cells (Fig. 1A) . Quantitative assessment indicated low Rxfp1 gene expression in the mouse aorta, with 30 -40% samples below the threshold for detection (C T value Ͼ 38). This increased to 85% in old Rln Ϫ/Ϫ mice. Although Rxfp1 expression was lower in the aorta of young Rln Ϫ/Ϫ mice, it was not significantly different from young Rln ϩ/ϩ mice (Fig. 1B) .
Vascular phenotypes in young Rln
Ϫ/Ϫ mice. The contraction response induced by L-NAME was significantly (t 14 ϭ 2.58, P ϭ 0.02) lower in young Rln Ϫ/Ϫ mice compared with young Rln ϩ/ϩ mice ( Fig. 2A) , demonstrating a reduction in basal NOS activity. This correlated with a significant (t 8 ϭ 2.32, P ϭ 0.05) decrease in eNOS protein in the aortae of Rln Ϫ/Ϫ mice (Fig.  2B ) but no corresponding change in Nos3 gene expression (Fig.  2C) . However, the ratio of phospho-Ser 1177 eNOS to total eNOS protein was significantly increased in these mice (Fig.  2D) , suggesting a compensatory mechanism to overcome the reduction in eNOS independent of changes in Nos3 gene expression. iNOS protein was unaffected by Rln deficiency (Fig. 2E) . Basal vascular superoxide production was significantly (t 20 ϭ 3.02, P ϭ 0.01) higher in aortae of 4-mo-young Rln Ϫ/Ϫ mice compared with Rln ϩ/ϩ mice (Fig. 3A) . There was an increase in NADPH oxidase 2 (gp91 phox ) protein expression, but it did not reach significance (Fig. 3C) . Conversely, there was no significant difference in nitrotyrosine levels (Fig. 3B) or Cu/Zn SOD (Fig. 3D) protein expression in the mouse aorta.
Vascular reactivity to ACh and GTN in young Rln
Ϫ/Ϫ mice. Cumulative concentration-response curves to the endotheliumindependent agonist GTN and endothelium-dependent agonist ACh are shown in Fig. 4, A and B, respectively. There was no evidence of vascular dysfunction in the aorta of young Rln Ϫ/Ϫ mice, as indicated by the similar relaxation responses to both ACh and GTN in Rln ϩ/ϩ and Rln Ϫ/Ϫ mice. Moreover, pEC 50 and R max were not significantly different between the genotypes (Table 2) . Pretreatment with L-NAME almost completely abolished the relaxation to ACh in both genotypes (Fig. 4C) , demonstrating that the major component of ACh-mediated relaxation in the aorta is NO. This was not significantly compromised by a lack of Rln. However, pretreatment with indomethacin revealed altered ACh-mediated relaxation in aortae of Rln Ϫ/Ϫ mice (Fig. 4D) , with a significant (t 14 ϭ 2.64, P ϭ 0.02) decrease in pEC 50 but not R max to ACh compared with Rln ϩ/ϩ mice ( Table 2 ). These data suggest altered NOmediated relaxation in the absence of vascular prostanoids. This was normalized by the addition of tempol (Fig. 4E) and apocynin ( Fig. 4F) , demonstrating that superoxide anions and ROS contributed to the increased oxidative stress in the aorta of young Rln Ϫ/Ϫ mice.
Molecular analysis of vascular prostanoid pathways revealed no significant difference in the expression of Ptgs1 (Fig. 5A) , Ptgs2 (Fig. 5B ), or PTGIS (Fig. 5C ) in the aorta between young Rln ϩ/ϩ and Rln Ϫ/Ϫ mice. However, Ptgir expression was Values are means Ϯ SE; n, number of aortic rings from separate animals. pEC50, sensitivity; Rmax, maximum relaxation; GTN, glyceryl trinitrate; L-NAME, N -nitro-L-arginine methyl ester; Rln Ϫ/Ϫ mice, Rln-deficient mice. #pEC50 significantly (P ϭ 0.02) lower than in wild-type (Rln ϩ/ϩ ) mice (by independent t-test).
significantly (t 11 ϭ 3.20, P ϭ 0.01) decreased in young Rln Ϫ/Ϫ mice ( Fig. 5D) , which was associated with a significant (t 7 ϭ 4.19, P ϭ 0.004) reduction in pEC 50 but not R max of aortae to the prostacyclin receptor agonist iloprost in young Rln Ϫ/Ϫ mice compared with Rln ϩ/ϩ mice (Fig. 5F ). pEC 50 and maximum contraction of aortae to the thromboxane A 2 mimetic U-46619 were not different between young Rln ϩ/ϩ and Rln Ϫ/Ϫ mice (Fig. 5E) .
Vascular phenotypes in old Rln Ϫ/Ϫ mice. The phenotypic differences associated with reduced NO availability in aortae of young Rln Ϫ/Ϫ mice did not persist in 16-mo-old Rln Ϫ/Ϫ mice. Basal NOS activity (Fig. 6A) , eNOS protein expression (Fig. 6B) , Nos3 gene expression (Fig. 6C) , the ratio of phospho-Ser 1177 eNOS to total eNOS (Fig. 6D) , and iNOS (Fig. 6E ) did not differ significantly between genotypes. However, comparisons between young and old Rln ϩ/ϩ mice revealed a reduction in L-NAME-induced contraction in the older mice (38.71 Ϯ 5.23% in young mice vs. 27.71 Ϯ 5.54% in old mice) and an increase between young and old Rln Ϫ/Ϫ mice (22.92 Ϯ 3.18% in young mice vs. 31.72 Ϯ 3.27% in old mice). Thus, basal NOS activity in aortae of old Rln ϩ/ϩ mice was negatively affected by aging, whereas NO-related phenotypes in young Rln Ϫ/Ϫ mice were not exacerbated with aging.
Vascular reactivity to ACh and GTN in old Rln
Ϫ/Ϫ mice. Cumulative concentration-response curves to GTN and ACh are shown in Fig. 7, A and B (Table 3) . Pretreatment with L-NAME almost completely abolished the relaxation to ACh in both genotypes (Fig. 7C) , but, in contrast to young mice, pretreatment with indomethacin did not significantly affect ACh-mediated relaxation in aortae of old Rln Ϫ/Ϫ mice compared with old Rln ϩ/ϩ mice (Fig. 7D ). There was, however, a significant (t 19 ϭ 2.66, P ϭ 0.02) reduction in pEC 50 to ACh in aortae of old control Rln ϩ/ϩ mice (6.84 Ϯ 0.14) compared with young control Rln ϩ/ϩ mice (7.35 Ϯ 0.13). It is likely that vasodilator NO pathways involved in ACh-mediated relaxation were compromised in old Rln ϩ/ϩ mice because pretreatment with indomethacin significantly (t 20 ϭ 2.87, P ϭ 0.01) reduced pEC 50 to ACh compared with young Rln ϩ/ϩ mice (pEC 50 ; young mice: 7.19 Ϯ 0.08 vs. old mice: 6.77 Ϯ 0.14).
In contrast, new phenotypes associated with vascular prostanoids developed in old Rln Ϫ/Ϫ mice (Fig. 8) . Ptgs1 expression in the aorta was significantly (t 10 ϭ 3.36, P ϭ 0.01) higher in old Rln Ϫ/Ϫ mice compared with old Rln ϩ/ϩ mice (Fig. 8A ), whereas Ptgs2 was significantly (t 11 ϭ 2.54, P ϭ 0.03) reduced (Fig. 8B) . There was no significant difference in either PTGIS or Ptgir expression between the genotypes (Fig. 8, C and D) . and Rln Ϫ/Ϫ mice. Numbers in bars are numbers of aortic rings from separate animals. *Significantly (P ϭ 0.01) lower than young Rln ϩ/ϩ mice; #pEC50 significantly (P ϭ 0.004) lower than Rln ϩ/ϩ mice.
DISCUSSION
The aims of the present study were to investigate the role of endogenous Rln in the aorta and test the hypothesis that vascular dysfunction occurs more rapidly with aging in Rln Ϫ/Ϫ mice. Our key findings were the increased superoxide production, reduced basal NOS activity, and decrease in total eNOS protein in the aorta of young Rln Ϫ/Ϫ mice. Furthermore, the relaxation response to ACh was altered in the presence of indomethacin in Rln Ϫ/Ϫ mice. Despite these vascular phenotypes, neither endothelium-dependent nor endothelium-independent vasorelaxation were adversely affected. Another key finding was that aging did not exacerbate the vascular phenotypes in Rln Ϫ/Ϫ mice. This is explained by aging per se in Rln ϩ/ϩ mice. For example, basal NOS activity in the aorta of old Rln ϩ/ϩ mice was negatively affected by aging, as was pEC 50 to ACh. Overall, our data suggest roles for endogenous Rln in mediating basal superoxide levels and NO bioavailability in the aorta of young mice. However, Rln deficiency does not significantly compromise vascular function in this artery or exacerbate endothelial dysfunction associated with aging to 16 mo.
Very little research has assessed the vasodilatory role of endogenous Rln in nonpregnant animals and male animals. The two published studies to date used resistance arteries, and both reported vascular dysfunction in Rln Ϫ/Ϫ mice (13, 17) . In small renal arteries, myogenic reactivity was increased (17) , although no underlying mechanism was identified. There was also a clear reduction in endothelium-dependent relaxation in mesenteric arteries of Rln Ϫ/Ϫ male mice, which was attributed to increased vasoconstrictor prostanoids (13) . This was not due to increased thromboxane receptor expression or changes in COX enzymes and was attributed to be due to the production of specific vasoconstrictor prostanoids. In the aorta, the underlying vascular phenotype in Rln Ϫ/Ϫ mice is different and associated with an altered contribution of NO. Rln treatment enhances vasodilation in small resistance arteries and the aorta through mechanisms involving endothelium-dependent NO (9, 14, 16, 18, 23) . These mechanisms include rapid phosphatidylinositol 3-kinase activation, increased Akt phosphorylation, enhanced eNOS phosphorylation at Ser 1177 and Ser 633 and dephosphorylation at Thr 495 , increased eNOS activity, and NO synthesis (5, 14, 16) . Thus, we predicted that some of these signaling pathways would be compromised in the aorta of Rln Ϫ/Ϫ mice. Total eNOS protein and basal NOS activity were reduced in younger Rln Ϫ/Ϫ mice, but eNOS phosphorylation at Ser 1177 was increased. It is possible that this was sufficient to maintain NO production to compensate for the increase in basal superoxide levels so that endothelium-dependent relaxation was not altered, which is evident by comparable levels of nitrotyrosine between genotypes of young mice. It has also been reported that Rln treatment upregulates iNOS in rat mesenteric arteries (14) and coronary endothelial cells (6) to stimulate intrinsic NO production. In our study, Rln deficiency did not affect iNOS protein, so this may also contribute to NO synthesis in the mouse aorta and maintaining endothelial function. This study in the aorta revealed, for the first time, increased basal superoxide production and reduced basal NO availability in blood vessels of young Rln Ϫ/Ϫ mice. In contrast, endothelium-dependent relaxation was comparable between the young genotypes, suggesting that ACh-evoked relaxation was unaffected by an increase in superoxide production at the basal level. Due to limited tissue, we are unable to detect stimulated measurements of superoxide and changes in phosphorylated proteins, which is a limitation of the present study. NOmediated relaxation was restored in aortae of young Rln Ϫ/Ϫ mice with either the membrane-permeable SOD mimetic tempol or ROS scavenger apocynin (3). This appears to be independent of SOD or NADPH oxidase 2 protein, as neither were compromised in Rln Ϫ/Ϫ mice. In the kidney cortex of ANG II-induced hypertensive rats, Rln treatment reduced NADPH oxidase activity (19) . This suggest that one possibility is that relaxation in the aorta of young Rln Ϫ/Ϫ mice could be associated with an increase in NADPH oxidase activity rather than its expression. An ex vivo study (5) using rat aortic rings incubated with TNF-␣ to stimulate endothelial dysfunction showed that Rln treatment attenuated both superoxide and nitrotyrosine production. Rln treatment also counteracted free radical-mediated tissue injury in ischemia-reperfusion-induced intestinal and renal injury (2, 15) . These effects were mediated, in part, by Rln-stimulated increases in SOD-1 expression and/or activity (2, 5) . This suggests that the mechanism by which endogenous Rln regulates basal superoxide production could differ from that of exogenous Rln, which often produces nonphysiological plasma Rln concentrations.
We also reported age-specific changes in basal NOS activity and endothelial function only in Rln ϩ/ϩ mice but not in Rln
mice. The phenotypes observed in the aorta of young Rln Ϫ/Ϫ mice were not apparent in the old mice, but this was driven by changes in old Rln ϩ/ϩ mice. It has been well established that aged vessels have increased oxidative stress associated with altered NOS activity (8, 21) . In the present study, superoxide production, NADPH oxidase 2, and nitrotyrosine were not measured in aortae of older mice due to difficulty in obtaining Rln Ϫ/Ϫ mice and therefore limited tissue availability in the aged group. As L-NAME-induced contraction and ACh-evoked NO-mediated relaxation were reduced in old Rln ϩ/ϩ but not Rln Ϫ/Ϫ mice, we speculate that this was due to increased oxidative stress in aortae of old Rln ϩ/ϩ mice and perhaps to a lesser extent in Rln Ϫ/Ϫ mice. In summary, the disappearance of the NO-related vascular phenotypes in older mice may be explained predominantly by aging in Rln ϩ/ϩ mice. Interestingly, blockade of prostaglandin production with indomethacin revealed that vasodilator NO pathways involved in ACh-mediated relaxation were altered because the ACh dose-response curve was shifted to right. Unlike the mesenteric artery (13) , there was no evidence in the aorta of vascular phenotypes in young Rln Ϫ/Ϫ mice related to reduced PGI 2 production, e.g., expression of key enzymes involved in PGI 2 synthesis (COX1, COX2, and PGI 2 synthase) were not affected. However, Ptgir expression was reduced, and there was a reduction in pEC 50 to the PGI 2 analog iloprost.
Our data also revealed age-dependent differences in prostanoid pathway components. COX-2 gene expression was decreased in old Rln Ϫ/Ϫ mice compared with old Rln ϩ/ϩ mice but did not differ from young Rln Ϫ/Ϫ mice. This phenotypic difference in COX-2 expression was, therefore, explained by the increase in old Rln ϩ/ϩ mice. Furthermore, both PGI 2 synthase and its receptor were increased in old mice of both genotypes. One interpretation of these data is the requirement for increased production of vasodilator prostanoids (via the COX enzymes and PGI 2 ) with aging or an increase in PGI 2 receptors to prevent the development of endothelial dysfunction. Conversely, the increases in COX-1, PGI 2 synthase and its receptor in old Rln Ϫ/Ϫ could explain why the altered NO relaxation response to ACh in the presence of indomethacin did not worsen with aging. One limitation of our study is conclusive evidence of altered production of prostanoids in older mice, but this was not possible with the relatively low animal numbers and the requirement of a larger tissue mass for such analysis. The relationship between Rln and prostanoids will be addressed in future studies involving in vivo Rln administration in rats and stimulated production of vascular prostanoids. We also considered that age-related changes in vascular phenotypes were underpinned by changes in the expression of Rln receptors (RXFP1) in the mouse aorta. Our data showed relatively low expression of Rxfp1 in this blood vessel and no difference between genotypes or ages. However, in several samples, Rxfp1 expression was considered below the threshold of detection (Ͼ38 cycles). This was more apparent in the aorta of old Rln Ϫ/Ϫ mice. As Rxfp1 expression was not decreased in the aorta of old Rln ϩ/ϩ mice, we conclude that the age-specific changes in basal NOS activity and prostanoid pathway components in these mice are not associated with changes in Rxfp1 expression. Similarly, aged-related differences in Rxfp1 expression in the rat mesenteric artery did not account for the reduced vasodilator response to exogenous Rln (22). Another explanation could be an age-related reduction in endogenous Rln in Rln ϩ/ϩ mice. We assessed Rln mRNA expression in the mouse aorta by RT-PCR (data not shown), but expression was below the level of detection so we were unable to record alterations in endogenous Rln in the aorta with aging.
The surprising finding was that neither endothelium-dependent (ACh-mediated) nor endothelium-independent (GTN-mediated) relaxation were adversely affected in the aorta of young or old Rln Ϫ/Ϫ mice despite the observed vascular phenotypes. In contrast, there is clear endothelial dysfunction in mesenteric and renal arteries of 5-mo-old Rln Ϫ/Ϫ mice (13, 17) . The degree to which Rln deficiency affects vascular function may be influenced by artery type. This idea has previously been suggested in Rln treatment studies. Despite the localization of RXFP1 in femoral arteries and veins and mesenteric veins of healthy young rats, there were no functional effects of Rln observed in these blood vessels (9) .
In conclusion, there was no progressive age-dependent alteration in vascular endothelial function in the aorta of Rln Ϫ/Ϫ mice. However, NO-mediated relaxation was altered in young Rln Ϫ/Ϫ mice. Importantly, our data show that endogenous Rln has a vasoprotective role because basal NOS activity and total eNOS protein expression were reduced in young Rln Ϫ/Ϫ mice and vascular superoxide production was increased.
